AHRQ: More evidence needed on DMARD use in juvenile arthritis

09/28/2011 | HealthDay News

Although disease-modifying anti-rheumatic drugs appear to be more effective for treating juvenile idiopathic arthritis than ibuprofen or steroids, not much evidence concerning long-term use exists, according to the Agency for Healthcare Research and Quality. Data indicated better health outcomes in children who received DMARDs, but the researchers noted that there was insufficient data to compare different classes of DMARDs.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC